2-Trifluormethyl-7-amino-oxazolo<5,4-b>pyridin | 30466-60-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶唑并吡啶类
• 英文名称: 2-Trifluormethyl-7-amino-oxazolo<5,4-b>pyridin
• 英文别名: 2-trifluoromethyl-oxazolo[5,4-b]pyridin-7-ylamine；2-(Trifluoromethyl)-[1,3]oxazolo[5,4-b]pyridin-7-amine
• CAS: 30466-60-5
• 化学式: C₇H₄F₃N₃O
• 分子量: 203.123
• InChiKey: DLOYEVDGDWRYIU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  64.9
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-氯-3,4-二氨基吡啶 、 三氟乙酸 在 三氟乙酸酐 作用下， 生成 2-Trifluormethyl-7-amino-oxazolo<5,4-b>pyridin
  参考文献：
  名称：

  Roechling,H.; Buechel,K.H., Chemische Berichte, 1971, vol. 104, p. 344 - 347

  摘要：

  DOI：

文献信息

• HETEROCYCLIC COMPOUNDS THAT INHIBIT THE KINASE ACTIVITY OF MNK USEFUL FOR TREATING VARIOUS CANCERS
  申请人：eFFECTOR Therapeutics, Inc.

  公开号：US20170145009A1

  公开（公告）日：2017-05-25

  The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula IA or Formula IB, as well as stereoisomers, tautomers or pharmaceutically acceptable salts thereof. For Formula IA and Formula IB compounds A 1 , A 2 , A 3 , A 4 , W 1 , W 2 , Y, X, R 1 , R 2 , R 3 , R 4a , R 4b , R 5a , R 5b , R 6 , R 7 , R 8 , R 9 , R 9a , R 9b , R 10 and subscript n are as defined in the specification. The inventive Formula IA and Formula IB compounds are inhibitors of Mnk and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.